{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:32:10Z","timestamp":1780677130405,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04503-9","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T09:35:41Z","timestamp":1764322541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of risk factors for Clostridioides difficile infection in patients with ulcerative colitis and development of a predictive nomogram"],"prefix":"10.1186","volume":"25","author":[{"given":"Kanghua","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"10","key":"4503_CR1","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk P, Yeshi K, Loukas A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci. 2024;45(10):892\u2013903.","journal-title":"Trends Pharmacol Sci"},{"key":"4503_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119674","volume":"558","author":"S Ziaei Chamgordani","year":"2024","unstructured":"Ziaei Chamgordani S, Yadegar A, Ghourchian HC. C. difficile biomarkers, pathogenicity and detection. Clin Chim Acta. 2024;558:119674.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"4503_CR3","first-page":"280","volume":"32","author":"F Salvati","year":"2024","unstructured":"Salvati F, Catania F, Murri R, et al. Clostridioides difficile infection: an update. Infez Med. 2024;32(3):280\u201391.","journal-title":"Infez Med"},{"issue":"11","key":"4503_CR4","doi-asserted-by":"publisher","first-page":"e0056724","DOI":"10.1128\/msphere.00567-24","volume":"9","author":"Y CUSHING-DAMM K C, CHEN","year":"2024","unstructured":"CUSHING-DAMM K C, CHEN Y, DU X, et al. Genetic insight into the relationship between inflammatory bowel disease and clostridioides difficile infection [J]. mSphere. 2024;9(11):e0056724.","journal-title":"mSphere"},{"issue":"5","key":"4503_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izad238","volume":"30","author":"L Cook","year":"2024","unstructured":"Cook L, Wong MQ, Rees WD, et al. Dysregulated immunity to Clostridioides difficile in IBD patients without a history of recognized infection. Inflamm Bowel Dis. 2024;30(5):820\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"4503_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/ibd\/izaa224","volume":"27","author":"P Palacios Argueta","year":"2021","unstructured":"Palacios Argueta P, Salazar M, Attar B, et al. 90-day specific readmission for Clostridium difficile infection after hospitalization with an inflammatory bowel disease flare: outcomes and risk factors. Inflamm Bowel Dis. 2021;27(4):530\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"4503_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","volume":"56","author":"H Nakase","year":"2021","unstructured":"Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021;56(6):489\u2013526.","journal-title":"J Gastroenterol"},{"issue":"7","key":"4503_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"LC Mcdonald","year":"2018","unstructured":"Mcdonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1\u201348.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4503_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4103\/sjg.sjg_118_24","volume":"30","author":"M Alghamdi","year":"2024","unstructured":"Alghamdi M, Alyousfi D, Mukhtar MS, et al. Association between vedolizumab and risk of clostridium difficile infection in patients with ulcerative colitis: a systematic review and meta-analysis. Saudi J Gastroenterol. 2024;30(6):346\u201352.","journal-title":"Saudi J Gastroenterol"},{"issue":"1","key":"4503_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/apt.17777","volume":"59","author":"EJ Spartz","year":"2024","unstructured":"Spartz EJ, Dedecker LC, Fansiwala KM, et al. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2024;59(1):89\u201399.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"4503_CR11","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/imj.16545","volume":"54","author":"R Jacob","year":"2024","unstructured":"Jacob R, Chu V, Ng W, et al. Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience. Intern Med J. 2024;54(12):2009\u201314.","journal-title":"Intern Med J"},{"issue":"47","key":"4503_CR12","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e359","volume":"38","author":"EM Song","year":"2023","unstructured":"Song EM, Choi A, Kim S, et al. The prevalence and risk factors of Clostridioides difficile infection in inflammatory bowel disease: 10-year South Korean experience based on the National Database. J Korean Med Sci. 2023;38(47):e359.","journal-title":"J Korean Med Sci"},{"key":"4503_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/1756284821997792","volume":"14","author":"E Voth","year":"2021","unstructured":"Voth E, Solanky D, Loftus EV, et al. Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection. Therap Adv Gastroenterol. 2021;14:1756284821997792.","journal-title":"Therap Adv Gastroenterol"},{"key":"4503_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123256","author":"P Kaazan","year":"2023","unstructured":"Kaazan P, Seow W, Yong S, et al. The impact of obesity on inflammatory bowel disease. Biomedicines.2023;11(12):3256. https:\/\/doi.org\/10.3390\/biomedicines11123256.","journal-title":"Biomedicines"},{"issue":"6","key":"4503_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036693","volume":"103","author":"X Gao","year":"2024","unstructured":"Gao X, Zhou H, Hu Z, et al. Primary clostridium difficile infection in patients with ulcerative colitis: case report and literature review. Medicine (Baltimore). 2024;103(6):e36693.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"4503_CR16","volume":"13","author":"S Markovic","year":"2021","unstructured":"Markovic S, Jankovic M, Kalaba A, et al. Infliximab rescue in acute severe ulcerative colitis complicated by Clostridium difficile infection: a case series. Cureus. 2021;13(10):e19019.","journal-title":"Cureus"},{"key":"4503_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.02.055","author":"S Ben-Horin","year":"2022","unstructured":"Ben-Horin S, Har-Noy O, Katsanos KH, et al. Corticosteroids and mesalamine versus corticosteroids for acute severe ulcerative colitis: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20(12):2868\u20132875.\u00a0https:\/\/doi.org\/10.1016\/j.cgh.2022.02.055.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"4503_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/00365521.2022.2121175","volume":"58","author":"B Gros","year":"2023","unstructured":"Gros B, Soto P, Causse M, et al. Impact of Clostridioides difficile infection in patients admitted with ulcerative colitis. Scand J Gastroenterol. 2023;58(3):232\u20139.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"4503_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.23736\/S0026-4806.20.07139-6","volume":"112","author":"W Sbeit","year":"2021","unstructured":"Sbeit W, Kadah A, Shahin A, et al. Predictors of in-hospital mortality among patients with clostridium difficile infection: a multicenter study. Minerva Med. 2021;112(1):124\u20139.","journal-title":"Minerva Med"},{"issue":"1","key":"4503_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295681","volume":"19","author":"N Ishida","year":"2024","unstructured":"Ishida N, Takahashi K, Asai Y, et al. Albumin change predicts failure in ulcerative colitis treated with adalimumab. PLoS One. 2024;19(1):e0295681.","journal-title":"PLoS One"},{"key":"4503_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1461801","volume":"11","author":"Z Fan","year":"2024","unstructured":"Fan Z, Zhou H, Zhang J, et al. Opportunistic infections changed before and after SARS-CoV-2 infection in inflammatory bowel disease patients: a retrospective single-center study in China. Front Med (Lausanne). 2024;11:1461801.","journal-title":"Front Med (Lausanne)"},{"key":"4503_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231189124","volume":"16","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, Yuan Y, Liu J, et al. A nomogram based on clinical factors to predict calendar year readmission in patients with ulcerative colitis. Therap Adv Gastroenterol. 2023;16:17562848231189124.","journal-title":"Therap Adv Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04503-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04503-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04503-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:31:15Z","timestamp":1767072675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04503-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4503"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04503-9","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was approved by Ganzhou People\u2019s Hospital Ethics Committee(No. GZSRMYY2024100015) in accordance with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"893"}}